To Evaluate The Efficacy of oral Unani formulation and Rogan Banafsha as Qatur-i-Anf(Nasal Drop) in Nazla Harr(Allergic Rhinitis):An Open Label Interventional Study

The study titled To Evaluate the Efficacy of Oral Unani Formulation and Roghan Banafsha as Qatur i Anf Nasal Drop in Nazla Harr Allergic Rhinitis An Open Label Interventional Study aims to scientifically assess the effectiveness and safety of traditional Unani medicine in the management of allergic rhinitis. Allergic rhinitis referred to as Nazla Harr in Unani literature is an IgE mediated condition that presents with symptoms such as sneezing nasal congestion watery nasal discharge and itching. It is a widespread condition that significantly impacts the quality of life and work performance of affected individuals. Although modern medicine offers various treatment options these often come with side effects such as drowsiness and impaired psychomotor function.

In this open label single arm interventional trial 40 patients aged between 18 and 60 years with clinically diagnosed allergic rhinitis will be selected from the OPD of State Unani Medical College and HAHRDM Hospital Prayagraj. The intervention consists of a polyherbal Unani decoction Joshanda made from Gule Banafsha Unnab Sapistan Tukhm Khatmi and Misri administered orally along with Roghan Banafsha used as a nasal drop Qatur i Anf. The treatment will be given for three weeks with weekly follow ups followed by a post treatment assessment in the fourth week.

The study will evaluate efficacy based on subjective parameters like nasal discharge sneezing nasal congestion nasal itching and eye irritation and objective measures such as serum IgE levels and symptom severity scores. Safety will be monitored through clinical examination and laboratory investigations. This research is designed to validate the traditional Unani approach and offer a low cost accessible and safe alternative to conventional therapies for allergic rhinitis.